Skip Nav Destination
Committee on Drugs
AAP Policy authored by the Committee on Drugs
From the American Academy of Pediatrics Clinical Report
Rohit P. Shenoi, MD, FAAP; Nathan Timm, MD, FAAP; COMMITTEE ON DRUGS; COMMITTEE ON PEDIATRIC EMERGENCY MEDICINE; Bridgette Jones, MD, FAAP; Kathleen Neville, MD, MS, MBA, FAAP; Jennifer Foster, MD, FAAP; Connie Houck, MD, FAAP; Matthew Laughon, MD, FAAP; Ian Paul, MD, FAAP; Routt J. Reigart, MD, FAAP; Janice Sullivan, MD, FAAP; John van den Anker, MD, PhD, FAAP; Joseph Wright, MD, MPH, FAAP; Terry Adirim, MD, MPH, FAAP; James Callahan, MD, FAAP; Michael Agus, MD, FAAP; Javier Gonzalez del Rey, MD, MEd, FAAP; Toni Gross, MD, MPH, FAAP; Madeline Joseph, MD, FAAP; Natalie Lane, MD, FAAP; Lois Lee, MD, MPH, FAAP; Elizabeth Mack, MD, FAAP; Prashant Mahajan, MD, MPH, MBA, FAAP; Jennifer Marin, MD, FAAP; Suzan Mazor, MD, FAAP
January 01 2020
From the American Academy of Pediatrics Clinical Report
Joseph D. Tobias, MD; Thomas P. Green, MD; Charles J. Coté, MD; SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE; COMMITTEE ON DRUGS; Rita Agarwal, MD; Corrie T.M. Anderson, MD; Courtney Alan Hardy, MD; Anita Honkanen, MD; Mohamed A. Rehman, MD; Kathleen Neville, MD; Constance S. Houck, MD; Bridgette Jones, MD; Ian M. Paul, MD; Janice E. Sullivan, MD; John N. Van Den Anker, MD
October 01 2016
From the American Academy of Pediatrics Policy Statement
COMMITTEE ON DRUGS; Kathleen Neville, MD; Jeffrey L. Galinkin, MD; Thomas P. Green, MD; Timothy D. Johnson, DO; Ian M. Paul, MD; Janice Sullivan, MD; John N. Van Den Anker, MD
April 01 2015
From the American Academy of Pediatrics Policy Statement
COMMITTEE ON DRUGS; Kathleen A. Neville, MD; Daniel A.C. Frattarelli, MD; Jeffrey L. Galinkin, MD; Thomas P. Green, MD; Timothy D. Johnson, DO; MMM; Ian M. Paul, MD; John N. Van Den Anker, MD
March 01 2014
From the American Academy of Pediatrics Clinical Report
Recognition and Management of Iatrogenically Induced Opioid Dependence and Withdrawal in Children
Free
Jeffrey Galinkin, MD; Jeffrey Lee Koh, MD; COMMITTEE ON DRUGS; SECTION ON ANESTHESIOLOGY AND PAIN MEDICINE; Daniel A. C. Frattarelli, MD; Thomas P. Green, MD; Timothy D. Johnson, DO; Kathleen A. Neville, MD; Ian M. Paul, MD; John N. Van Den Anker, MD; Carolyn Fleming Bannister, MD; Joseph Tobias, MD; Corrie T. M. Anderson, MD; Kenneth R. Goldschneider, MD; David Mark Polaner, MD
January 01 2014
From the American Academy of Pediatrics Clinical Report
Hari Cheryl Sachs, MD; COMMITTEE ON DRUGS; Daniel A. C. Frattarelli; Jeffrey L. Galinkin; Thomas P. Green; Timothy Johnson; Kathleen Neville; Ian M. Paul; John Van den Anker
September 01 2013
From the American Academy of Pediatrics Clinical Report
Mark L. Hudak, MD; Rosemarie C. Tan, MD; THE COMMITTEE ON DRUGS; THE COMMITTEE ON FETUS AND NEWBORN; Daniel A. C. Frattarelli, MD; Jeffrey L. Galinkin, MD; Thomas P. Green, MD; Kathleen A. Neville, MD; Ian M. Paul, MD; John N. Van Den Anker, MD; Lu-Ann Papile, MD; Jill E. Baley, MD; Vinod K. Bhutani, MD; Waldemar A. Carlo, MD; James Cummings, MD; Praveen Kumar, MD; Richard A. Polin, MD; Kasper S. Wang, MD; Kristi L. Watterberg, MD
February 01 2012
From the American Academy of Pediatrics Clinical Report
Janice E. Sullivan, MD; Henry C. Farrar, MD; the SECTION ON CLINICAL PHARMACOLOGY AND THERAPEUTICS; COMMITTEE ON DRUGS
March 01 2011
From the American Academy of Pediatrics Clinical Report
Robert E. Shaddy, MD; Scott C. Denne, MD; The Committee on Drugs and Committee on Pediatric Research
April 01 2010
From the American Academy of Pediatrics
Mary A. Hegenbarth, MD; and the Committee on Drugs
February 01 2008
